Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03791034
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Sponsor: Samsung Medical Center
View on ClinicalTrials.gov
Summary
The aim of the study is to evaluate whether peripheral circulating cell-free tumor DNA (cfDNA) can aid screening of recurrence after complete resection of early stage non-small cell lung cancer.
Official title: Prospective Feasibility Study of Cell Free Circulating Tumor DNA for the Diagnosis and Treatment Monitoring in Early-stage Non-small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
700
Start Date
2017-08-28
Completion Date
2026-12-31
Last Updated
2021-05-11
Healthy Volunteers
No
Conditions
Locations (1)
Samsung Medical Center
Seoul, South Korea